CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395 | +44 (0) 20 3951 8071
info@oxonepi.com

NEWS & EVENTS

ICPE2021

OXON at ICPE21 All Access Virtual Conference on 23-25 August, 2021

OXON is delighted to be supporting ICPE again this year with a virtual exhibition booth from which we will be happy to speak with you about our specialisation in data collection, secondary data and hybrid real world studies, pragmatic trials and meta-analyses to help plan, design and implement RWE for safety, market access and drug development.

Cholesterol-dementia cohort study

Lancet study shows cholesterol in middle-age ‘linked to Alzheimer’s more than 10 years later’

The study, published in Lancet Healthy Longevity, suggests that high levels of cholesterol in middle-age are associated with an increased risk of developing dementia and Alzheimer’s disease. The retrospective cohort study ‘Blood cholesterol and risk of dementia in a retrospective cohort of over 1.8 million people over two decades’, presented at the 35th International Conference…
Read more

RWE & Trials Live Masterclass Session 4: ‘Individualizing Benefit Risk’

RWE Masterclass 4: ‘Individualizing Benefit Risk’ Session 4: ‘Individualizing Benefit Risk’, will take place on Wednesday, 16 June 2021 at 5 pm CEST MORE INFORMATION|REGISTER HERE   SUMMARY: Conventional methods of benefit-risk overly focus on overall results; subgroups have limitations, and the relative importance of events may not be considered. Individualizing benefit-risk more precisely would…
Read more

OXON Masterclass Series- Session3

RWE & Trials Live Masterclass Session 3: ‘Non-randomised Comparative Studies’

RWE Masterclass 3: ‘Non-randomised comparative studies’ Non-randomised comparative studies will be the main topic of the next session of our Real-World Evidence Masterclass Series. This Masterclass mini-series are meant for attendees to learn about perspectives on RWE studies with the help of two experts in this particular field: Professor Stuart Pocock, renewed trialist and statistician, and…
Read more

Masterclass 2 Propensity Scores

RWE & Trials Live Masterclass Session 2: ‘The Tyranny of Propensity Scores’

RWE Live Masterclass 2: ‘The Tyranny of Propensity Scores’ Propensity Scores will be the main topic of the next session of our Real-World Evidence Masterclass Series. This Masterclass mini-series are meant for attendees to learn about perspectives on RWE studies with the help of two experts in this particular field: Professor Stuart Pocock, renewed trialist…
Read more

RWE Masterclass

OXON’s RWE & Trials Free Live Masterclass Series 2021

Real-World Evidence & Trials Masterclass Series 2021  OXON Epidemiology will be hosting a Real-World Evidence Masterclass Series for all professionals interested in learning about the role of Real-World Data studies and their pros and cons compared with trials. Real-World Evidence (RWE) is a key opportunity to better understand the diseases and patient needs. Besides, all…
Read more

""

OXON wins first prize for a spotlight poster at ICPE20 All Access Virtual Conference

OXON is delighted to be supporting ICPE again this year with a virtual exhibition booth from which we will be happy to speak with you about our specialisation in data collection, secondary data and hybrid real world studies, pragmatic trials and meta-analyses to help plan, design and implement RWE for safety, market access and drug development.

""

OXON at ICPE20 All Access Virtual Conference on 16-17 Sep 2020

OXON is delighted to be supporting ICPE again this year with a virtual exhibition booth from which we will be happy to speak with you about our specialisation in data collection, secondary data and hybrid real world studies, pragmatic trials and meta-analyses to help plan, design and implement RWE for safety, market access and drug development.

""

OXON’s COVID-19 Research Programme-the role of comparative observational studies

OXON Epidemiology leads a group of international European academics and clinicians to conduct the ‘RAPID COVID-19’ research programme of hospitalised COVID-19 patients.

""

OXON’s COVID-19 Research Programme

OXON collaborates with academics and clinicians in not-for-profit international programme to evaluate non-randomised comparative studies of treatments for COVID-19 and prognostic factors